DLT Resolution Inc. (NASDAQ:DLTI) | Finanzwire

Basculer en Français

8605	Companies
141153	Keywords
77082	Articles
75430	Press releases

Home
Companies
DLT Resolution Inc.

PRESS RELEASE

published on 02/14/2024 at 17:10, 1 year 1 month ago

RETRANSMISSION: DLT Resolution Inc. Initiates Strategic Acquisition, Securing 19.9% Stake in Ciscom Corp
DLT Resolution Inc. announces acquisition of 19.9% stake in Ciscom Corp. to drive growth strategy. Planned multiple add-on acquisitions to expand market footprint and empower future growth in ICT sector

Growth Strategy Acquisition ICT Sector DLT Resolution Inc. Future Growth
PRESS RELEASE

published on 02/14/2024 at 13:40, 1 year 1 month ago

DLT Resolution Inc. Initiates Strategic Acquisition, Securing 19.9% Stake in Ciscom Corp
DLT Resolution Inc. acquires 19.9% of Ciscom Corp.'s common shares, enhancing its growth strategy. The move aims to expand market presence through innovative portfolio development and add-on acquisitions

Growth Strategy Acquisition Market Expansion DLT Resolution Inc. Ciscom Corp.

Accesswire

Published on 04/09/2025 at 15:15, 56 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 1 hour 11 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 1 hour 11 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 14:50, 1 hour 21 minutes ago

Commerce Resources and Mont Royal Resources Enter Into Arrangement Agreement to Create a Canadian-Focused Critical Minerals Development Company
Published on 04/09/2025 at 14:30, 1 hour 41 minutes ago

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

View all ACCESSWIRE

EQS Group

Published on 04/09/2025 at 15:35, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/09/2025 at 15:34, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/09/2025 at 15:33, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Published on 04/09/2025 at 15:32, 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 04/09/2025 at 15:31, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc

Les Echos

Published on 04/09/2025 at 08:00, 8 hours 11 minutes ago

Museum Studio becomes a majority shareholder in Lord Cultural Resources
Published on 04/09/2025 at 07:00, 9 hours 11 minutes ago

Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Published on 04/08/2025 at 19:24, 20 hours 46 minutes ago

Thales makes available its Universal Registration Document 2024
Published on 04/08/2025 at 18:46, 21 hours 24 minutes ago

Availability of the preparatory documents for the combined General Meeting of 29 April 2025
Published on 04/08/2025 at 17:57, 22 hours 13 minutes ago

Statement of transactions in own shares from March 31, 2025 to April 03, 2025

View all LES ECHOS COMFI WIRE